FDA
Betamethasone Valerate
The FDA lists this product in 20 strengths and forms.
Indications
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse reactions
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.
Composition
- Active ingredients
- BETAMETHASONE VALERATE EQ 0.1% BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BETAMETHASONE VALERATE 0.12% · Aerosol, foamANDA215832-001 · Prescription
- BETAMETHASONE VALERATE EQ 0.1% BASE · CreamNDA018860-002 · Discontinued
- BETAMETHASONE VALERATE EQ 0.1% BASE · LotionNDA018866-001 · Prescription
- BETAMETHASONE VALERATE 0.12% · Aerosol, foamANDA208204-001 · Prescription
- BETAMETHASONE VALERATE 0.12% · Aerosol, foamANDA078337-001 · Prescription
- BETAMETHASONE VALERATE EQ 0.1% BASE · Ointment
At a glance
- Brand name
- Betamethasone Valerate
- Route
- Topical
- Dosage form
- Cream
- Applicant
- Fougera Pharms Inc
- Status
- Prescription
- FDA approval
- 31 Aug 1983
- Application
- NDA018861-001